Kiniksa Pharmaceuticals International (KNSA) Current Assets (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Current Assets of $668.63 million for Q2 2026, up 59.1% from $420.31 million a year earlier and up 12.5% from the prior quarter.
Kiniksa Pharmaceuticals International (KNSA) Current Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International posted Current Assets of $527.18 million, up 58.9% from FY2024.
- Current Assets has increased for four consecutive years, with a five-year compound annual growth rate of 9.6% (FY2020 to FY2025).
- By year, Current Assets came in at $331.8 million in FY2024 (+20.1%), $276.3 million in FY2023 (+13.7%), $243.06 million in FY2022 (+23.7%) and $196.45 million in FY2021 (-41.1%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets in data going back to Q4 2017.
- Year over year, Current Assets has now increased in each of the last 16 quarters, with growth averaging 43.8% over the last eight quarters.
- The high point for year-over-year Current Assets in five years was Q1 2026 (growth of 66.9%); the low point was Q3 2021 (a decline of 42.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $594.17 million (Q1 2026), $527.18 million (Q4 2025) and $475.53 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.87 Bn | 10.61 Bn | 220.03 Mn | 668.63 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 668.63 Mn |
| Mar 31, 2026 | 594.17 Mn |
| Dec 31, 2025 | 527.18 Mn |
| Sep 30, 2025 | 475.53 Mn |
| Jun 30, 2025 | 420.31 Mn |
| Mar 31, 2025 | 355.91 Mn |
| Dec 31, 2024 | 331.80 Mn |
| Sep 30, 2024 | 311.30 Mn |
| Jun 30, 2024 | 301.02 Mn |
| Mar 31, 2024 | 270.59 Mn |
| Dec 31, 2023 | 276.30 Mn |
| Sep 30, 2023 | 256.11 Mn |
| Jun 30, 2023 | 246.04 Mn |
| Mar 31, 2023 | 231.50 Mn |
| Dec 31, 2022 | 243.06 Mn |
| Sep 30, 2022 | 241.82 Mn |
| Jun 30, 2022 | 179.94 Mn |
| Mar 31, 2022 | 198.76 Mn |
| Dec 31, 2021 | 196.45 Mn |
| Sep 30, 2021 | 217.51 Mn |
Kiniksa Pharmaceuticals International Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=KNSA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();